These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2934730)

  • 41. Reversible bone-marrow suppression primarily involving granulopoiesis following the use of Ticlopidine.
    Quaglino D; Venturoni L; Cretara G; Ricciotti M
    Haematologica; 1982; 67(6):940-1. PubMed ID: 6819199
    [No Abstract]   [Full Text] [Related]  

  • 42. Possible mechanism of action of ticlopidine on committed granulocyte macrophage precursors.
    Quaglino D; Salladini G; Ricciotti M
    Haematologica; 1984; 69(3):257-62. PubMed ID: 6432638
    [No Abstract]   [Full Text] [Related]  

  • 43. Morbidity and mortality during renal replacement therapy: dialysis versus transplantation.
    Straathof-Galema L; van Saase JL; Verburgh CA; de Fijter JW; Schut NH; van Dorp WT
    Clin Nephrol; 2001 Mar; 55(3):227-32. PubMed ID: 11316243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
    Wolfe RA; Ashby VB; Milford EL; Ojo AO; Ettenger RE; Agodoa LY; Held PJ; Port FK
    N Engl J Med; 1999 Dec; 341(23):1725-30. PubMed ID: 10580071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ticlopidine: blood and liver involvement?].
    Biour M; Toussaint P; Duhamel G; Canuel C; Krulick M; Calmus Y
    Therapie; 1982; 37(2):222-4. PubMed ID: 7112492
    [No Abstract]   [Full Text] [Related]  

  • 46. Dose-finding study of rivaroxaban in hemodialysis patients.
    De Vriese AS; Caluwé R; Bailleul E; De Bacquer D; Borrey D; Van Vlem B; Vandecasteele SJ; Emmerechts J
    Am J Kidney Dis; 2015 Jul; 66(1):91-8. PubMed ID: 25804678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral hemorrhage under rivaroxaban.
    Stöllberger C; Zuntner G; Bastovansky A; Finsterer J
    Int J Cardiol; 2013 Sep; 167(6):e179-81. PubMed ID: 23651821
    [No Abstract]   [Full Text] [Related]  

  • 48. Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Satayathum S; Pisoni RL; McCullough KP; Merion RM; Wikström B; Levin N; Chen K; Wolfe RA; Goodkin DA; Piera L; Asano Y; Kurokawa K; Fukuhara S; Held PJ; Port FK
    Kidney Int; 2005 Jul; 68(1):330-7. PubMed ID: 15954924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Side effects of ticlopidine; clinical observation and immunological study].
    de Fraiture WH; Claas FH; Meyboom RH
    Ned Tijdschr Geneeskd; 1982 Jun; 126(23):1051-4. PubMed ID: 6213869
    [No Abstract]   [Full Text] [Related]  

  • 50. Metabolic side effects of the platelet-inhibitory drug ticlopidine.
    Berglund U; Wallentin L
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():281-3. PubMed ID: 3159214
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cholestatic hepatitis. Presumptive role of ticlopidine].
    Eugene C; Lefebvre JF; Gury B; Quevauvilliers J
    Sem Hop; 1983 Nov; 59(42):2923-4. PubMed ID: 6318329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute coronary syndrome and rivaroxaban: not so fast..
    Prescrire Int; 2012 Nov; 21(132):260. PubMed ID: 23210253
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584
    [No Abstract]   [Full Text] [Related]  

  • 54. Dialysis chains and placement on the waiting list for a cadaveric kidney transplant.
    Zhang Y; Thamer M; Kshirsagar O; Cotter DJ; Schlesinger MJ
    Transplantation; 2014 Sep; 98(5):543-51. PubMed ID: 24798304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergency surgery and trauma in patients treated with the new oral anticoagulants: dabigatran, rivaroxaban, and apixaban.
    Moorman ML; Nash JE; Stabi KL
    J Trauma Acute Care Surg; 2014 Sep; 77(3):486-94; quiz 486-94. PubMed ID: 25159255
    [No Abstract]   [Full Text] [Related]  

  • 56. Severe ticlopidine-induced cholestatic syndrome.
    Mambelli E; Mancini E; Casanova S; Di Felice A; Santoro A
    Blood Purif; 2007; 25(5-6):441-5. PubMed ID: 18004066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The wish of chronic hemodialysis patients for renal transplantation].
    Liu Y; Ren B; Xiao S
    Zhonghua Hu Li Za Zhi; 1996 May; 31(5):272-4. PubMed ID: 8945134
    [No Abstract]   [Full Text] [Related]  

  • 58. [Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].
    Canaud B; Mion C
    Nephrologie; 1995; 16(1):129-35. PubMed ID: 7700413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of ticlopidine on peripheral obliterating arteriopathy].
    Stiegler H; Hess H; Mietaschk A; Trampisch HJ; Ingrisch H
    Dtsch Med Wochenschr; 1984 Aug; 109(33):1240-3. PubMed ID: 6381015
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [20 patients with chronic ischemia of the legs treated with ticlopidine].
    Velasco A; Olabarría I; Ramila P; Domínguez MJ; Iriarte JA
    Angiologia; 1985; 37(5):236-42. PubMed ID: 4073584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.